Tissue

Breast tumor tissue array (7 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (7 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (6 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (6 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (5 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (5 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (4 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (4 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (3 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (3 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (20 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (20 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (19 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (19 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (18 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (18 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (17 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (17 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (16 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (16 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (15 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (15 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (14 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (14 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (13 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (13 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (12 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (12 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (11 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (11 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (10 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor tissue array (10 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (24 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores

Breast tumor survey tissue array (24 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores

Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores

Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Breast tissue array, normal adjacent tissue of HBre-Duc170Sur-01, 90 cases. 1 core/case, with survival information

Breast tissue array, normal adjacent tissue of HBre-Duc170Sur-01, 90 cases. 1 core/case, with survival information

Breast tissue array, 4 cases/4 cores

Breast tissue array, 4 cases/4 cores

Breast medullary carcinoma tissue array, including TNM, clinical stage, 24 cases/ 24 cores

Breast medullary carcinoma tissue array, including TNM, clinical stage, 24 cases/ 24 cores

Breast mastitis tissue array, 20 cases/40 cores

Breast mastitis tissue array, 20 cases/40 cores

Breast mastitis tissue array, 20 cases/ 40 cores

Breast mastitis tissue array, 20 cases/ 40 cores

Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores

Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores

Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases/80 cores

Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases/80 cores

Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases/80cores, replacing BR802

Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases/80cores, replacing BR802

Breast invasive ductal carcinoma tissue microarray (75 cases), replacing HBre-Duc068Bch-01. ER, PR, Her2 available

Breast invasive ductal carcinoma tissue microarray (75 cases), replacing HBre-Duc068Bch-01. ER, PR, Her2 available

Breast invasive ductal carcinoma tissue array, with cancer adjacent breast tissue and adjacent normal breast tissue, including pathology grade,TNM and clinical stage, 21 cases/63 cores,replacing BC08032

Breast invasive ductal carcinoma tissue array, with cancer adjacent breast tissue and adjacent normal breast tissue, including pathology grade,TNM and clinical stage, 21 cases/63 cores,replacing BC08032

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1505d

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1505d

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing BR246a

Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing BR246a

Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing BR808, BC08014

Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing BR808, BC08014

Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases/100 cores, replacing BC08118

Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases/100 cores, replacing BC08118

Breast invasive ductal carcinoma tissue array, 40 cases, 3 cases with normal adjacent tissue. NAT.

Breast invasive ductal carcinoma tissue array, 40 cases, 3 cases with normal adjacent tissue. NAT.

Breast invasive ductal carcinoma tissue array, 31 cases. Tumor and matched normal adjacent tissue

Breast invasive ductal carcinoma tissue array, 31 cases. Tumor and matched normal adjacent tissue

Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases/48 cores

Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases/48 cores

Breast invasive ductal carcinoma tissue array (64 cases) and other types of breast carcinoma (4 cases)

Breast invasive ductal carcinoma tissue array (64 cases) and other types of breast carcinoma (4 cases)

Breast invasive ductal carcinoma tissue array (52 cases)

Breast invasive ductal carcinoma tissue array (52 cases)

Breast invasive ductal carcinoma (62 cases) and NAT.

Breast invasive ductal carcinoma (62 cases) and NAT.

Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores

Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores

Breast hyperplasia tissue array, 80 cases/80 cores

Breast hyperplasia tissue array, 80 cases/80 cores